{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:44:42Z","timestamp":1776001482473,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T22:35:23Z","timestamp":1623278123000},"page":"4219-4230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries"],"prefix":"10.1016","volume":"39","author":[{"given":"Chelsea S.","family":"Lutz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Biggerstaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Rolfes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-9591","authenticated-orcid":false,"given":"Kathryn E.","family":"Lafond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Azziz-Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael M.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.05.006_b0005","doi-asserted-by":"crossref","DOI":"10.7326\/AITC201709050","article-title":"Influenza","author":"Uyeki","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.vaccine.2021.05.006_b0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3201\/eid1903.120394","article-title":"Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009\u20132010","volume":"19","author":"Borse","year":"2013","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.05.006_b0015","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.vaccine.2013.06.082","article-title":"Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009","volume":"31","author":"Jorgensen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.006_b0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12889-017-4058-5","article-title":"Policy perspectives on post pandemic influenza vaccination in Ghana and Malawi","volume":"17","author":"Sambala","year":"2017","journal-title":"BMC Public Health."},{"key":"10.1016\/j.vaccine.2021.05.006_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121717","article-title":"The Lao Experience in Deploying Influenza A(H1N1)pdm09 Vaccine: Lessons Made Relevant in Preparing for Present Day Pandemic Threats","volume":"10","author":"Xeuatvongsa","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.006_b0030","unstructured":"World Health Organization. Report of the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative. 2012. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44795\/9789241564427_eng.pdf;jsessionid=0E52713E77BB4C924C51B056CDFE4788?sequence=1. Accessed February 25, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0035","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.vaccine.2019.11.025","article-title":"Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic","volume":"38","author":"Porter","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0040","doi-asserted-by":"crossref","unstructured":"Collin N, de Radigues X, World Health Organization HNVTF. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine. 2009;27:5184-6.","DOI":"10.1016\/j.vaccine.2009.06.034"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.05.006_b0045","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2011.02.079","article-title":"WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer","volume":"29","author":"Friede","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0050","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2017 Revision, DVD Edition. 2017. https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/. Accessed January 12, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12462","article-title":"Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka","volume":"11","author":"Nasreen","year":"2017","journal-title":"Bangladesh. Influenza Other Respir Viruses."},{"key":"10.1016\/j.vaccine.2021.05.006_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002225","article-title":"Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 Southern hemisphere countries","volume":"7","author":"Opatowski","year":"2011","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2021.05.006_b0065","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/jmv.23622","article-title":"Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008\u20132010","volume":"85","author":"Sam","year":"2013","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.vaccine.2021.05.006_b0070","unstructured":"Shindo, N. Update on epidemiology and disease burden of Pandemic (H1N1) 2009. In: World Health Organization SAGE Meeting: 2009 October 27-29. https:\/\/www.who.int\/immunization\/sage\/SAGE_epi_Oct_09_GIP_final_NS.pdf. Accessed April 10, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0075","article-title":"Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting: Peru","volume":"14","author":"Munayco","year":"2009","journal-title":"Eurosurveillance Weekly"},{"key":"10.1016\/j.vaccine.2021.05.006_b0080","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. 2019. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.05.006_b0090","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1016\/j.vaccine.2018.10.026","article-title":"An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States","volume":"36","author":"Tokars","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0095","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1016\/j.vaccine.2020.10.069","article-title":"Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6\u201359 months in Suzhou, China, 2011\/12 to 2015\/16 influenza seasons","volume":"38","author":"Zhang","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0100","unstructured":"Centers for Disease Control and Prevention. The 2009 H1N1 Pandemic: Summary highlights, April 2009-April 2010. https:\/\/www.cdc.gov\/h1n1flu\/cdcresponse.htm. Accessed February 19, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0105","unstructured":"World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines. https:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090713\/en\/. Accessed Febraury 5, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajic.2010.09.011","article-title":"High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand","volume":"39","author":"Kiertiburanakul","year":"2011","journal-title":"American Journal of Infection Control"},{"key":"10.1016\/j.vaccine.2021.05.006_b0115","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.vaccine.2017.02.059","article-title":"Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis","volume":"35","author":"Lansbury","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0120","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1128\/JCM.00229-11","article-title":"Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations","volume":"49","author":"Veguilla","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.05.006_b0125","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/ciu1175","article-title":"Estimating the potential effects of a vaccine program against an emerging influenza pandemic\u2013United States","volume":"60","author":"Biggerstaff","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.05.006_b0130","unstructured":"World Health Organization. Pandemic influenza vaccine manufacturing process and timeline: pandemic (H1N1) 2009 briefing note 7. 2009. https:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090806\/en\/. Accessed June 5, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0135","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1016\/j.vaccine.2016.08.019","article-title":"The 2015 global production capacity of seasonal and pandemic influenza vaccine","volume":"34","author":"McLean","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-018-0079-z","article-title":"Cell culture-derived influenza vaccines in the severe 2017\u20132018 epidemic season: a step towards improved influenza vaccine effectiveness","volume":"3","author":"Barr","year":"2018","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2021.05.006_b0145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/hv.18757","article-title":"Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic","volume":"8","author":"Lopez-Macias","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.vaccine.2021.05.006_b0150","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14760584.2018.1541408","article-title":"Universal influenza vaccines: from viruses to nanoparticles","volume":"17","author":"Wang","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.vaccine.2021.05.006_b0155","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response\u2013lessons from the H1N1 influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2021.05.006_b0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.med.050908.132031","article-title":"H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic","volume":"61","author":"Sambhara","year":"2010","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.vaccine.2021.05.006_b0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMp038238","article-title":"Influenza vaccine\u2013outmaneuvering antigenic shift and drift","volume":"350","author":"Treanor","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2021.05.006_b0170","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1016\/j.vaccine.2019.06.049","article-title":"The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships","volume":"37","author":"Bresee","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0175","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.vaccine.2016.12.056","article-title":"Seasonal vaccines - Critical path to pandemic influenza response","volume":"35","author":"Zhang","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0180","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2011.06.107","article-title":"Factors associated with uptake of vaccination against pandemic influenza: a systematic review","volume":"29","author":"Bish","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0185","unstructured":"World Health Organization. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. 2011. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241503082_eng.pdf. Accessed July 29, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/ers.11.60","article-title":"Measuring the benefits of school closure interventions to mitigate influenza","volume":"5","author":"Chowell","year":"2011","journal-title":"Expert Rev Respir Med."},{"key":"10.1016\/j.vaccine.2021.05.006_b0195","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mcm.2011.09.027","article-title":"A modeling study of school closure to reduce influenza transmission: A case study of an influenza A (H1N1) outbreak in a private Thai school","volume":"55","author":"Modchang","year":"2012","journal-title":"Mathematical and Computer Modeling."},{"key":"10.1016\/j.vaccine.2021.05.006_b0200","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1098\/rsif.2010.0715","article-title":"Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective","volume":"8","author":"Carrasco","year":"2011","journal-title":"Journal of the Royal Society, Interface"},{"key":"10.1016\/j.vaccine.2021.05.006_b0205","unstructured":"World Health Organization. Changes in reporting requirements for pandemic (H1N1) 2009 virus infection. 16 July 2009. https:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_surveillance_20090710\/en\/. Accessed June 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0210","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.vaccine.2011.11.092","article-title":"Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean","volume":"30","author":"Ropero-Alvarez","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0215","unstructured":"World Health Organization. WHO Western Pacific Region. https:\/\/www.who.int\/westernpacific#. Accessed May 14, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0220","unstructured":"World Health Organization. WHO African Region Country Offices. https:\/\/www.afro.who.int\/countries. Accessed May 14, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0225","unstructured":"World Health Organization. Pan American Health Organization Countries and Centers: Subregion. https:\/\/www.paho.org\/hq\/index.php?option=com_wrapper&view=wrapper&Itemid=2005&lang=en. Accessed May 14, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0230","unstructured":"World Health Organization. WHO Regional Office for South-East Asia. http:\/\/www.searo.who.int\/en\/. Accessed May 14, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0235","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Cambodia, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0240","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Ghana, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0245","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Honduras, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0250","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Kenya, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0255","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Mongolia, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0260","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Paraguay, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0265","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Senegal, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0270","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. South Africa, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0275","unstructured":"World Health Organization. Influenza FluNet: Influenza Laboratory Surveillance Information. Sri Lanka, Week 17 2009 - Week 52 2010. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/flunet\/en\/. Accessed February 4, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0280","unstructured":"The World Bank. Data: Cambodia. 2019. https:\/\/data.worldbank.org\/country\/cambodia. Accessed April 23, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0285","unstructured":"The World Bank. Data: Ghana. 2019. https:\/\/data.worldbank.org\/country\/ghana. Accessed May 21, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0290","unstructured":"The World Bank. Data: Honduras. 2019. https:\/\/data.worldbank.org\/country\/honduras. Accessed April 23, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0295","unstructured":"The World Bank. Data: Kenya. 2019. https:\/\/data.worldbank.org\/country\/kenya. Accessed April 23, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0300","unstructured":"The World Bank. Data: Mongolia. 2019. https:\/\/data.worldbank.org\/country\/mongolia. Accessed April 23, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0305","unstructured":"The World Bank. Data: Paraguay. 2019. https:\/\/data.worldbank.org\/country\/paraguay. Accessed April 23, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0310","unstructured":"The World Bank. Data: Senegal. 2019. https:\/\/data.worldbank.org\/country\/senegal. Accessed May 21, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0315","unstructured":"The World Bank. Data: South Africa. 2019. https:\/\/data.worldbank.org\/country\/south-africa. Accessed April 23, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0320","unstructured":"The World Bank. Data: Sri Lanka. 2019. https:\/\/data.worldbank.org\/country\/sri-lanka. Accessed May 6, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0325","doi-asserted-by":"crossref","first-page":"806","DOI":"10.15585\/mmwr.mm6630a2","article-title":"Meningitis Outbreak Caused by Vaccine-Preventable Bacterial Pathogens - Northern Ghana, 2016","volume":"66","author":"Aku","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.vaccine.2021.05.006_b0330","first-page":"757","article-title":"Outbreak of measles--Venezuela and Colombia, 2001-2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.05.006_b0335","first-page":"237","article-title":"Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013","volume":"63","author":"Sheikh","year":"2014","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.vaccine.2021.05.006_b0340","unstructured":"Partnership for Influenza Vaccine Introduction. Mongolia. https:\/\/pivipartners.org\/mongolia\/. Accessed April 16, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0345","unstructured":"Outbreak news. Yellow fever, Paraguay. Wkly Epidemiol Rec. 2008;83:105"},{"key":"10.1016\/j.vaccine.2021.05.006_b0350","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3201\/eid2206.151652","article-title":"Post-Ebola Measles Outbreak in Lola, Guinea, January-June 2015(1)","volume":"22","author":"Suk","year":"2016","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.05.006_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055682","article-title":"Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009\u20132011","volume":"8","author":"Ntshoe","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.006_b0360","unstructured":"UNICEF. 150,000 Rohingya children in Bangladesh to be vaccinated amid threat of disease outbreak. 2017. https:\/\/www.unicef.org\/press-releases\/150000-rohingya-children-bangladesh-be-vaccinated-amid-threat-disease-outbreak. Accessed May 7, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0365","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.vaccine.2013.07.005","article-title":"Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010","volume":"31","author":"Njuguna","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.006_b0370","unstructured":"World Health Organization. Human resources for health country profiles: Cambodia. 2014. http:\/\/www.wpro.who.int\/hrh\/documents\/publications\/wpr_hrh_country_profile_cambodia_upload_ver1.pdf. Accessed April 15, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0375","unstructured":"Ghana Ministry of Health. Ghana Health Workforce Observatory: Human Resources for Health Country Profile. 2011. http:\/\/www.moh.gov.gh\/wp-content\/uploads\/2016\/02\/Ghana-hrh-country-profile.pdf. Accessed May 21, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0380","unstructured":"Pan American Health Organization\/World Health Organization. Health System Profile, Honduras, Central America: Monitoring and Analysis of Health Systems Change\/Reform. 2009. http:\/\/www.paho.org\/PAHO-USAID\/dmdocuments\/Health_System_Profile-Honduras_2009.pdf. Accessed April 22, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0385","unstructured":"Kenya Ministry of Health. Kenya Health Workforce Reprt: The Status of Healtcare Professionals in Kenya, 2015. https:\/\/www.taskforce.org\/wp-content\/uploads\/2018\/07\/KHWF_2017Report_Fullreport_042317-MR-comments.pdf."},{"key":"10.1016\/j.vaccine.2021.05.006_b0390","unstructured":"World Health Organization. Human resources for health country profiles: Mongolia. 2014. https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/10533\/9789290616382_eng.pdf. Accessed April 15, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0395","unstructured":"World Health Organization. Global Health Workforce Alliance: Paraguay. 2019. https:\/\/www.who.int\/workforcealliance\/countries\/pry\/en\/. Accessed April 17, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0400","unstructured":"World Health Organization African Health Observatory. Senegal Factsheet of Health Statistics 2018. 2018. http:\/\/www.aho.afro.who.int\/profiles_information\/images\/e\/e3\/Senegal-Statistical_Factsheet.pdf. Accessed May 29, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0405","unstructured":"Health Systems Trust. Indicator tool: South Africa. 2017. http:\/\/indicators.hst.org.za\/Human%20Resources\/Health%20Personnel\/sahr_133\/IND?start=start. Accessed April 17, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0410","unstructured":"Samarage S. Health Care Systems: Sri Lanka. In: ILO\/IOM\/WHO Migration and Human Resources for Health: From Awareness to Action: 2006 March 23-24; Geneva, Switzerland. https:\/\/www.iom.int\/jahia\/webdav\/site\/myjahiasite\/shared\/shared\/mainsite\/microsites\/IDM\/workshops\/mhrh23240306\/presentation_samarage.pdf"},{"key":"10.1016\/j.vaccine.2021.05.006_b0415","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1750-2659.2012.00416.x","article-title":"Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar","volume":"7","author":"Bali","year":"2013","journal-title":"India. Influenza Other Respir Viruses."},{"key":"10.1016\/j.vaccine.2021.05.006_b0420","unstructured":"Kenya Ministry of Public Health and Sanitation. Guidelines for Asthma Management in Kenya. 2011. http:\/\/apps.who.int\/medicinedocs\/documents\/s21973en\/s21973en.pdf. Accessed Febraury 12, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0425","unstructured":"The International Study of Asthma and Allergies in Children. ISAAC Phase Three Data: Viet Nam. http:\/\/isaac.auckland.ac.nz\/phases\/phasethree\/results\/results.php. Accessed May 7, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0430","unstructured":"The International Study of Asthma and Allergies in Childhood. ISAAC Phase Three Data: Cote d'Ivoire. http:\/\/isaac.auckland.ac.nz\/phases\/phasethree\/results\/results.php. Accessed May 21, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40733-017-0032-3","article-title":"Asthma: epidemiology of disease control in Latin America - short review","volume":"3","author":"Sole","year":"2017","journal-title":"Asthma Res Pract."},{"key":"10.1016\/j.vaccine.2021.05.006_b0440","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.alit.2015.07.009","article-title":"Prevalence of childhood asthma in Ulaanbaatar, Mongolia in 2009","volume":"65","author":"Yoshihara","year":"2016","journal-title":"Allergol Int."},{"issue":"7","key":"10.1016\/j.vaccine.2021.05.006_b0445","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7196\/SAMJ.2018.v108i7.13162","article-title":"The increasing burden of asthma in South Afircan children: A call to action","volume":"108","author":"Masekela","year":"2018","journal-title":"South African Medical Journal"},{"key":"10.1016\/j.vaccine.2021.05.006_b0450","unstructured":"The International Study of Asthma and Allergies in Childhood. ISAAC Phase Three Data: Sri Lanka. http:\/\/isaac.auckland.ac.nz\/phases\/phasethree\/results\/results.php. Accessed May 6, 2019."},{"key":"10.1016\/j.vaccine.2021.05.006_b0455","first-page":"P4100","article-title":"Prevalence of current asthma and COPD, and their overlap in adults in Phnom Penh","volume":"44","author":"Makino","year":"2014","journal-title":"Cambodia. European Respiratory Journal."},{"key":"10.1016\/j.vaccine.2021.05.006_b0460","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Public Health."},{"key":"10.1016\/j.vaccine.2021.05.006_b0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5415\/apallergy.2014.4.1.25","article-title":"Prevalence of asthma and allergic rhinitis among adult population in Ulaanbaatar","volume":"4","author":"Sonomjamts","year":"2014","journal-title":"Mongolia. Asia Pac Allergy."},{"key":"10.1016\/j.vaccine.2021.05.006_b0470","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2004.030932","article-title":"Wheeze, asthma diagnosis and medication use: a national adult survey in a developing country","volume":"60","author":"Ehrlich","year":"2005","journal-title":"Thorax"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:00:03Z","timestamp":1759402803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21005570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":94,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21005570"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}